The Use of Nasal Phenylephrine in Infants With Bronchiolitis

Phase 2

Completed

• Conditions: Bronchiolitis

• Registration Number: NCT00373802
• Lead Sponsor: Akron Children's Hospital

Brief Summary

Drops of either saline or phenylephrine are placed in the nose of infants less than 12 months of age to determine if it helps them to breathe easier.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-01
• Primary Completion: 2005-06
• Study Completion: 2005-06
• Study First Submitted: 2006-09-07
• Study First Submitted QC: 2006-09-07
• Study First Posted: 2006-09-08
• Status Verified: 2009-01
• Last Update Submitted: 2009-01-09
• Last Update Posted: 2009-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Age 4 weeks to 12 months; admitting diagnosis of bronchiolitis; admitted to hospital's bronchiolitis pathway, admitted during weekdays, need for nasal suctioning.

Exclusion Criteria

• Congenital heart disease, history of hypertension, previous wheezing, prior use of inhaled corticosteroids, gestational age at birth of <34 weeks.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Respiratory Distress Assessment Index at 5 minutes, 60 minutes, and 180 minutes.

Secondary Outcome Measures

Name	Time	Method
Respiratory rate, oxygen saturation and use of supplemental oxygen at 5, 60, and 180 minutes.